Paperpal Prime Logo

International Urology and Nephrology : Impact Factor & More

eISSN: 1573-2584pISSN: 0301-1623

Key Metrics

CiteScore
3.5
H-Index
60
Impact Factor
< 5
SJR
Q2Urology
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Urology and Nephrology

International Urology and Nephrology Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1968
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Urology and Nephrology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Urology and Nephrology

Functional outcomes and retreatment rates after iTIND implantation in a real-world Italian multicenter cohort: the importance of patient selection.
  • 8 Aug 2026
  • International urology and nephrology
Efficacy, safety, and quality of life outcomes of [177Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.
  • 8 Aug 2026
  • International urology and nephrology
Additional considerations on PhenoAge construction in the association between proteinuria and biological aging.
  • 8 Aug 2026
  • International urology and nephrology
C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study).
  • 7 Aug 2026
  • International urology and nephrology
Impact of race on comorbidity burden and clinical outcomes among Southeast Asians with lupus nephritis: a single-center retrospective study.
  • 7 Aug 2026
  • International urology and nephrology
Proteinuria and PhenoAge acceleration: an association requiring recalculation.
  • 7 Aug 2026
  • International urology and nephrology
Functional outcomes and retreatment rates after iTIND implantation in a real-world Italian multicenter cohort: the importance of patient selection.
  • 8 Aug 2026
  • International urology and nephrology
Efficacy, safety, and quality of life outcomes of [177Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.
  • 8 Aug 2026
  • International urology and nephrology
Additional considerations on PhenoAge construction in the association between proteinuria and biological aging.
  • 8 Aug 2026
  • International urology and nephrology
C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study).
  • 7 Aug 2026
  • International urology and nephrology
Impact of race on comorbidity burden and clinical outcomes among Southeast Asians with lupus nephritis: a single-center retrospective study.
  • 7 Aug 2026
  • International urology and nephrology
Proteinuria and PhenoAge acceleration: an association requiring recalculation.
  • 7 Aug 2026
  • International urology and nephrology

FAQs on International Urology and Nephrology